Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MORRISSEY, R. E.
Right arrow Articles by KIMMEL, C. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MORRISSEY, R. E.
Right arrow Articles by KIMMEL, C. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

research-article

The Developmental Toxicity of Orally Administered Oxytetracycline in Rats and Mice1

RICHARD E. MORRISSEY2, ROCHELLE W. TYL*,3, CATHERINE J. PRICE*, THOMAS A. LEDOUX*,4, JERRY R. REEL*,5, LORETTA L. PASCHKE*,6, MELISSA C. MARR* and CAROLE A. KIMMEL{dagger},7

National Institute of Environmental Health Sciences, National Toxicology Program P.O. Box 12233, Research Triangle Park, North Carolina 2 7709 *Chemistry and Life Sciences, Center for Life Sciences Toxicology, Research Triangle Institute P.O. Box 12194, Research Triangle Park, North Carolina 27709 {dagger}Perinatal and Postnatal Evaluation Branch, Division of Teratogenesis Research, National Center for Toxicological Research/National Toxicology Program Jefferson, Arkansas 72079

The Developmental Toxicity of Orally Administered Oxytetracycline in Rats and Mice. MORRISSEY, R.E., TYL, R.W., PRICE, C.J., LEDOUX, T.A., REEL, J.R., PASCHKE, L.L., MARR, M.C, AND KJMMEL, C.A. (1986). Fundam. Appl. Toxicol. 7, 434-443. Timed-pregnant CD rats and CD-1 mice were dosed by gavage with oxytetracycline hydrochloride (OXT) in corn oil on gestational days (gd) 6-15 (0, 1200, 1350, or 1500 mg/kg/day for rats; 0, 1325, 1670, or 2100 mg/kg/day for mice). Deaths among treated females occurred in a dose-related manner in all OXT dose groups (2-7%, mice; 5-24%, rats), but no maternal deaths occurred in the vehicle control groups. Significant dose-related decreases in maternal weight gain during treatment, as well as for corrected gestational weight gain (i.e., maternal gestational weight gain minus gravid uterine weight), were observed at all doses in rats but not in mice. Gravid uterine weight was reduced in a dose-related manner only in mice, with the high-dose group significantly reduced compared to the control group. At termination (gd 20, rats; gd 17, mice), the status of uterine implantation sites was recorded and live fetuses were weighed. Fetuses were examined for external, visceral, and skeletal abnormalities. There were no significant effects of OXT in either species on the incidence of postimplantation loss (resorptions plus dead fetuses) or malformations. In both species, there was a significant trend toward reduced fetal body weight, and each group of rats receiving OXT was significantly reduced compared to the control group. Administration of OXT during organogenesis at doses exceeding the therapeutic range for humans produced maternal and fetal toxicity, but did not produce any treatment-related increase in malformations.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.